DarioHealth Statistics

Total Valuation

DarioHealth has a market cap or net worth of $31.12 million. The enterprise value is $33.61 million.

Market Cap	31.12M
Enterprise Value	33.61M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

DarioHealth has 44.46 million shares outstanding. The number of shares has increased by 73.72% in one year.

Current Share Class	44.46M
Shares Outstanding	44.46M
Shares Change (YoY)	+73.72%
Shares Change (QoQ)	-39.94%
Owned by Insiders (%)	14.18%
Owned by Institutions (%)	23.78%
Float	35.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.34
Forward PS	0.93
PB Ratio	0.42
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.41.

Current Ratio	2.01
Quick Ratio	1.75
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -59.05% and return on invested capital (ROIC) is -28.57%.

Return on Equity (ROE)	-59.05%
Return on Assets (ROA)	-24.04%
Return on Invested Capital (ROIC)	-28.57%
Return on Capital Employed (ROCE)	-50.36%
Revenue Per Employee	$138,782
Profits Per Employee	-$148,351
Employee Count	202
Asset Turnover	0.22
Inventory Turnover	1.80

Taxes

In the past 12 months, DarioHealth has paid $164,000 in taxes.

Income Tax	164,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.36% in the last 52 weeks. The beta is 1.59, so DarioHealth's price volatility has been higher than the market average.

Beta (5Y)	1.59
52-Week Price Change	-36.36%
50-Day Moving Average	0.71
200-Day Moving Average	0.77
Relative Strength Index (RSI)	44.43
Average Volume (20 Days)	173,548

Short Selling Information

The latest short interest is 2.96 million, so 6.66% of the outstanding shares have been sold short.

Short Interest	2.96M
Short Previous Month	2.90M
Short % of Shares Out	6.66%
Short % of Float	8.25%
Short Ratio (days to cover)	16.63

Income Statement

In the last 12 months, DarioHealth had revenue of $28.03 million and -$29.97 million in losses. Loss per share was -$0.57.

Revenue	28.03M
Gross Profit	19.46M
Operating Income	-48.57M
Pretax Income	-52.73M
Net Income	-29.97M
EBITDA	-41.21M
EBIT	-48.57M
Loss Per Share	-$0.57

Full Income Statement

Balance Sheet

The company has $27.85 million in cash and $30.34 million in debt, giving a net cash position of -$2.48 million or -$0.06 per share.

Cash & Cash Equivalents	27.85M
Total Debt	30.34M
Net Cash	-2.48M
Net Cash Per Share	-$0.06
Equity (Book Value)	73.70M
Book Value Per Share	1.73
Working Capital	19.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$32.13 million and capital expenditures -$113,000, giving a free cash flow of -$32.24 million.

Operating Cash Flow	-32.13M
Capital Expenditures	-113,000
Free Cash Flow	-32.24M
FCF Per Share	-$0.73

Full Cash Flow Statement

Margins

Gross margin is 69.41%, with operating and profit margins of -173.25% and -159.80%.

Gross Margin	69.41%
Operating Margin	-173.25%
Pretax Margin	-159.22%
Profit Margin	-159.80%
EBITDA Margin	-147.01%
EBIT Margin	-173.25%
FCF Margin	n/a

Dividends & Yields

DarioHealth does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-73.72%
Shareholder Yield	-73.72%
Earnings Yield	-96.28%
FCF Yield	-103.58%

Analyst Forecast

The average price target for DarioHealth is $2.50, which is 257.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.50
Price Target Difference	257.14%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	19.53%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 18, 2019. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Nov 18, 2019
Split Type	Reverse
Split Ratio	0.05:1

Scores

DarioHealth has an Altman Z-Score of -5.38 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.38
Piotroski F-Score	3